Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm鈥檚 SEC reports can stretch past 300 pages, filled with aerospace engineering terms, acquisition footnotes, and leveraged finance tables鈥攏o wonder analysts keep typing "TransDigm SEC filings explained simply" into search bars. If you have ever hunted for "TransDigm insider trading Form 4 transactions" or struggled to trace how a tiny bolt-on acquisition affects cash flow, you know the challenge.
Stock Titan solves that problem. Our AI ingests every TransDigm quarterly earnings report 10-Q filing and delivers plain-English summaries within minutes of EDGAR release. AG真人官方-time alerts flag each new TransDigm Form 4 insider transactions real-time entry, letting you review TransDigm executive stock transactions Form 4 before the market opens. We also break down segment margins, backlog shifts, and debt covenants in a dedicated TransDigm earnings report filing analysis panel鈥攕aving hours of manual spreadsheet work.
Beyond the numbers, governance matters. The TransDigm proxy statement executive compensation section is auto-tagged, so you can compare pay packages year over year in seconds. Any sudden disclosure? Our dashboard lists every TransDigm 8-K material events explained module, highlighting acquisitions, debt issuances, or leadership changes. Looking for historical context? One click shows the TransDigm annual report 10-K simplified alongside prior years. Whether you鈥檙e monitoring "understanding TransDigm SEC documents with AI" or scanning for aerospace supply-chain risk, Stock Titan provides comprehensive coverage of all filing types with continuously updated data, expert context, and AI-powered clarity.
TransDigm Group Co-Chief Operating Officer Joel Reiss reported significant insider trading activity on June 20, 2025. The transactions involved both the exercise of stock options and subsequent sales of common stock:
- Exercised 3,000 stock options at $284.97 per share (originally granted with expiration date 11/08/2027)
- Sold a total of 3,000 shares in multiple transactions at prices ranging from $1,410.11 to $1,431.11 per share
- Net reduction in directly held common stock from 6,600 to 3,600 shares
- Retains 59,000 stock options following the transactions
The trading pattern suggests a typical exercise-and-sell transaction where the executive exercised options and immediately sold the acquired shares, realizing a significant profit given the substantial difference between the exercise price ($284.97) and market prices (approximately $1,410-$1,431). The transactions were executed through multiple trades at varying price points, indicating a structured selling approach.